Microtest Diagnostics
London · Founded 2001
About Microtest Diagnostics
Microtest Diagnostics was spun out of London’s Imperial College in 2002 with a mission to provide automated multiplex in-vitro diagnostic tests in the areas of Allergy, Autoimmune, Influenza and Infectious Disease. Following more than 10 years of development and over USD $10 million in R&D investment, Microtest Diagnostics recently CE-marked the ADAM™ instrument. The company operates with a highly skilled team of trained professionals with expertise across numerous fields including product, software and hardware design, instrument and assay development, regulatory approvals and quality control. Our facilities are certified ISO13485:2003 Medical devices and ISO 9001:2008 for the design and development of microarray test devices.
Company Facts
- Founded: 2001
- Legal name: Microtest Matrices Ltd
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.5M
- Last round: Series Unknown (Jan 2016)
- Website: microtestdx.com
- Phone: +44 (0)20 7594 7999
Social Profiles
Canonical: https://fsome.com/organization/microtest-diagnostics-8260819 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.